SCANDIPHARM BEGINS MARKETING FLUTTER CYSTIC FIBROSIS DEVICE
This article was originally published in The Gray Sheet
Executive Summary
SCANDIPHARM BEGINS MARKETING FLUTTER CYSTIC FIBROSIS DEVICE in the U.S., with sales to CF clinics and respiratory therapists starting Aug. 3. The personal respiratory therapy device for patients with cystic fibrosis was granted 510(k) clearance in May.